Insomnia
Insomnia usually refers to a subjective experience in which patients are not satisfied with the sleep time and/or quality and their daytime social functions are affected, including difficulty falling asleep, frequent awakenings and/or waking up too early in the morning. It can cause symptoms such as fatigue, restlessness, general discomfort, lack of energy, slow reaction, headache, and poor memory. Its greatest impact is on the mental aspect, and a serious case can lead to schizophrenia. Common clinical types include: primary sleep disorder, secondary sleep disorder, and pseudo-insomnia.
-
Site of disease:
psychology -
Infectious :
Not contagious -
Frequent population:
All people, those who are not in good spirits,... -
Related symptoms:
Difficulty falling asleep Waking up early in the morning and unable to fall asleep again Difficulty falling asleep or waking up easily Light sleep Tension insomnia -
Concurrent disease:
Related Drugs
Schisandra granules
Manufacturer:
Jiangxi Xincheng Pharmaceutical Co., Ltd.
Shengui Lurong Pill
Manufacturer:
Jiuzhitang Co., Ltd.
Compound Schisandra Syrup
Indication: Used to improve symptoms such as dizziness, headache, fatigue, palpitations and insomnia caused by neurasthenia.
Ultra-low frequency transcranial magnetic stimulator
Indication: It has an auxiliary therapeutic effect on insomnia.
Ultra-low frequency transcranial magnetic stimulator
Indication: It has an auxiliary therapeutic effect on insomnia.
ESZOPICLONE_- eszopiclone_tablet, film coated
Indication: Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). Eszopiclone tablets has been shown to decrease sleep latency and improve sleep maintenance (1).
Manufacturer:
A-S Medication Solutions
HALCION- triazolam_tablet
Indication: Halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Halcion is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
Manufacturer:
Pharmacia & Upjohn Company LLC
TEMAZEPAM- temazepam_capsule
Indication: Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
Manufacturer:
Sun Pharmaceutical Industries, Inc.
Related Ingredients
-
Anise oil list
8007-70-3 -
Propachlor list
1918-16-7 -
OLIBANUM GUM list
8050-07-5 -
MYRRH GUM list
9000-45-7 -
Sodium 3-phosphoglycerate list
17603-42-8